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Abstract
Rationale Across species, effort-related motivation can be assessed by testing behaviour under a progressive ratio (PR) schedule
of reinforcement. However, to date, PR tasks for rodents have been available using traditional operant response systems only.
Objectives Touchscreen operant response systems allow the assessment of behaviour in laboratory rodents, using tasks that share
high face validity with the computerised assessments used in humans. Here, we sought to optimise a rat touchscreen variant of PR
and validate it by assessing the effects of a number of manipulations known to affect PR performance in non-touchscreen paradigms.
Methods Separate groups of male Sprague-Dawley rats were trained on PR schedules with either linear (PR4) or exponential
(PREXP) schedules of reinforcement. PR performance was assessed in response to manipulations in reward outcome. Animals
were tested under conditions of increased reward magnitude and following reward devaluation through a prefeeding procedure.
Subsequently, the effects of systemic administration of the dopamine D2/D3 receptor antagonist raclopride and the
psychostimulant d-amphetamine were examined as traditional pharmacological methods for manipulating motivation.
Results Rats reinforced under PR4 and PREXP schedules consistently showed differential patterns of response rates within
sessions. Furthermore, both PR4 and PREXP schedules were sensitive to suppression by prefeeding or raclopride administration.
Performance under both schedules was facilitated by increasing reward magnitude or d-amphetamine administration.
Conclusions Taken together, these findings mirror those observed in lever-based PR paradigms in rats. This study therefore
demonstrates the successful validation of the rat touchscreen PR task. This will allow for the assessment of motivation in rats,
within the same touchscreen apparatus used for the assessment of complex cognitive processes in this species.
Keywords Progressive ratio schedule . Touchscreen . Motivation . Rat
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Impaired motivated behaviour represents an unmet clinical
need in a number of neuropsychiatric and neurodegenerative
disorders. Such impairment, often referred to as ‘apathy’, are a
common and debilitating symptom in disorders such as
schizophrenia (Foussias et al. 2014), major depression
(Treadway and Zald 2011), Alzheimer’s disease (Landes et
al. 2001), Parkinson’s disease (Pedersen et al. 2009) and
Huntington’s’ disease (Naarding et al. 2009). Across disorders, apathy can severely affect patients’ quality of life (Ho
et al. 1998; Boyle et al. 2003; Starkstein et al. 2006; Aarsland
et al. 2007) and has been linked to accelerated disease progression and increased mortality rates (Starkstein et al. 2006;
Spalletta et al. 2015). Standard treatment approaches for these
disorders have little impact upon apathy (Fervaha et al. 2015;
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Lanctôt et al. 2017), highlighting the need for novel pharmacological targets. A key stage of developing novel treatments
typically involves displaying the effectiveness of a compound
in a preclinical rodent model. Therefore, the ability to measure
motivated behaviours in rodents is of crucial importance.
Motivated behaviour can be divided into activational and
directional components (Robbins and Everitt 1982; Salamone
1988). Directional processes allow behaviour to be directed
towards appetitive and away from aversive stimuli.
Activational aspects of motivation allow organisms to overcome costs or obstacles that are associated with obtaining
goals (Salamone 1988). In a number of disorders associated
with motivational impairments, activational processes appear
disrupted (Barch et al. 2014; Chong et al. 2015; Salamone et
al. 2016). Activational components of motivated behaviour
can be probed in the laboratory through studying the exertion
of effort. One widely used assay involves studying behaviour
under a progressive ratio (PR) schedule of reinforcement
(Hodos 1961). This task probes the ability of an organism to
maintain instrumental responding (such as lever pressing or
nose-poking) under increasing work demands. As the response requirement increases, an animal will eventually cease
responding. The amount of effort an animal is willing to expend in pursuit of appetitive reinforcement, expressed as the
maximum number of responses to obtain a single reward, is
referred to as the breakpoint (BP, Stewart 1975). PR schedules
have been used to study effort exertion across a number of
species including rats (Hodos 1961); mice (Randt and
Quartermain 1972); pigeons (Dardano and Sauerbrunn
1964); nonhuman primates (Griffiths et al. 1975) and humans
(Roane et al. 2001).
One recent refinement in preclinical animal testing has
been the development of touchscreen operant
response systems (Bussey et al. 2012; Hvoslef-Eide et al.
2015). These systems allow the assessment of a number of
cognitive domains including attentional processes and longterm and working memory (Horner et al. 2013; Mar et al.
2013; Oomen et al. 2013) within a single environment.
These systems also allow for the use of assays that share a
high degree of face validity with the automated computerised
testing batteries increasingly used in clinical populations
(Sahakian and Owen 1992; Barnett et al. 2010; Bland et al.
2016) and nonhuman primates (Weed et al. 1999). Although
face validity does not guarantee construct validity, it may help
facilitate cross-species translation of results. Previous research
has shown that, similar to lever and nose-poke manipulanda,
rodent touchscreens can support the sustained repetitive response behaviour required in ratio schedules such as PR,
and that this schedule can be successfully implemented in
mice using the touchscreen system (Heath et al. 2015). The
development of a validated rat touchscreen PR test would
allow the assessment of motivation in the rat using the same
reinforcers, responses and test setting as those used in the
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assessment of other complex behavioural constructs in the
same apparatus. This would allow motivated behaviour to be
assessed alongside and in a comparable way to other cognitive
processes as part of a battery approach in situations where the
rat is the favoured species. In spite of general consistency
between touchscreen-based assays and traditional leverbased or nose-poke systems (cf Humby et al. 1999;
Romberg et al. 2013), there have been reports of differential
sensitivity to pharmacological manipulations in mice (see
Heath et al. 2015). Therefore, it is necessary to verify the
sensitivity of the touchscreen-based PR task in rats to manipulations previously shown to affect performance.
PR tasks can vary in the nature of the schedule of reinforcement used. Some PR schedules increase in a linear fashion
(e.g. Skjoldager et al. 1993; Aberman et al. 1998;
Bensadoun et al. 2004; Heath et al. 2015), whereas others
employ exponentially increasing ratios (e.g. Poncelet et al.
1983; Mobini et al. 2000; Rickard et al. 2009). It is not known
whether manipulations that affect PR performance differentially affect behaviour reinforced under these different schedule types. We therefore assessed performance on two separate
reinforcement schedules: the linear PR4 and the exponential
PREXP schedules. We then sought to determine how these
schedules were affected by a number of manipulations that
have been previously been shown to affect performance.
Initially, we modulated the reward outcome value. Firstly, this
was achieved by increasing the magnitude of reward, which
was hypothesised, based on previous reports, to increase
breakpoint (Skjoldager et al. 1993; Eagle et al. 1999;
Rickard et al. 2009). Secondly, the reinforcer was devalued
through a prefeeding procedure, which was predicted to decrease breakpoints (Skjoldager et al. 1993; Eagle et al. 1999).
Subsequently, performance was assessed following systemic
administration of dopaminergic compounds. Based on previous reports, it was predicted that administration of the D2/D3
receptor antagonist raclopride would disrupt PR performance
(Cheeta et al. 1995; Aberman et al. 1998). Finally, it was
predicted that PR performance would be facilitated following
systemic d-amphetamine administration (Poncelet et al. 1983;
Mobini et al. 2000; Bensadoun et al. 2004).

Methods
Animals
Twenty-four male Sprague-Dawley rats (Charles River, UK)
were used in the current experiment. Animals were group
housed (four per cage) in a light- and temperature-controlled
environment (lights on 1900-0700). All testing took place in
the animals’ dark cycle. Following at least 7 days habituation
to the facility, animals were placed on a programme of controlled feeding and maintained at no less than 85% of their free
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feeding body weight. All experiments were regulated under
the Animals (Scientific Procedures) Act 1986 Amendment
Regulations 2012 and following ethical review by the
University of Cambridge Animal Welfare and Ethical
Review Body (AWERB).

Apparatus
All testing took place within automated rat touchscreen operant conditioning chambers (Campden Instruments Ltd.,
Loughborough, UK) described in detail previously (Horner
et al. 2013). The operant chambers consisted of black plastic
walls in a trapezoidal shape (height 30 cm, length 33 cm,
width 25 cm at screen, 13 cm at magazine). The operant
chambers were contained within light and sound-attenuating
boxes. Each operant chamber was fitted with a 38.1-cm touchsensitive LCD screen. Each screen was equipped with infrared
(IR) beams positioned less than 5 mm away from the screen,
which detected responses without requiring any force to be
applied to the screen itself. On the opposing side was a magazine connected to a pellet dispenser that delivered standard
45 mg dustless pellets (TestDiet, Indiana, USA). The food tray
was fitted with a light and an IR beam that registered magazine entries. Front and rear IR beams were fitted to monitor the
rats’ activity within the operant chamber. Black plastic masks
were fitted to the touchscreens that had five 9 cm2 square
response apertures, spaced 1 cm apart.

Pretraining
Behavioural testing consisted of one session per day (5–7 days
per week). All animals were initially given a 20-min habituation session. During this session, the boxes were active but no
stimuli were presented. Following this, rats underwent 1 day
of screen press training. A white square stimulus was presented in the central aperture for 30 s. A single response to this
stimulus resulted in three food pellets being delivered.
Stimulus offset and a short tone (1000 ms, 3 kHz) accompanied reward delivery. Following a 5-s inter-trial interval (ITI)
the stimulus returned to the screen. If no response was made
within 30 s, the trial ended and a single food pellet was delivered, accompanied by stimulus offset and the tone. Each session was terminated following 100 rewards being delivered or
45 min having elapsed.

Fixed ratio training
Rats then underwent fixed ratio (FR) 1 training. During these
sessions, a single response to the central stimulus was required
for a single pellet reward delivery. Reward delivery was again
accompanied by the tone. A 5-s inter-trial interval (ITI) was
employed. Each session was terminated following 45 min or
100 trials being completed. All animals were required to
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complete 100 trials within the 45 min before moving on to
the next stage of training. The subsequent training stage
consisted of FR5 responding, where five responses were required for each reward delivery. The first four responses in a
trial were accompanied with a shorter ‘click’ tone (10 ms,
3 kHz) and a brief (500 ms) stimulus offset. The stimulus
offset and brief ‘click’ tone were added to provide audiovisual feedback to the rat of a successful stimulus response.
The fifth response to the stimulus completed the trial and
resulted in delivery of reward and the longer duration tone.
All other parameters were identical to the FR1 stage of training. Each session was terminated following 100 trials (i.e. 500
target responses) or after 45 min. Each animal was required to
complete 100 trials within a session before being placed on a
PR schedule of reinforcement.

Progressive ratio
Animals were randomly assigned to either a linear (PR4) or
exponential (PREXP) schedule (n = 12 each). The PREXP
schedule chosen is commonly used in research, whereas the
PR4 schedule is that used in the mouse touchscreen equivalent
that can stably support behaviour at a level that can be bidirectionally manipulated by pharmacological interventions
in touchscreens (Heath et al. 2015). On both schedules, the
number of target responses required increased following completion of each trial. On the linear schedule, the response requirement began at one and increased by four on each subsequent trial (yielding response requirements of 1, 5, 9, 13, 17
etc.). The exponential schedule increased according to the
formula (5 * e(0.2*n)- 5), where n is the trial number, yielding
response requirements of 1, 2, 4, 6, 9, 12 etc., to the nearest
whole number. If no response was made to the touchscreen
within 180 s, on either schedule, the session was terminated
(based upon previous reports, Wirtshafter and Stratford 2010;
Klinkenberg and Blokland 2011; Enkel et al. 2014); otherwise, sessions ended after 45 min elapsing.

Outcome manipulations
Outcome manipulation probes were delivered in a withinsubject cross-over design. Firstly, rats underwent a reward
magnitude probe. On these days, rats received either a standard (single pellet) or an increased (three pellet) reward following each completed ratio. The groups were
counterbalanced so that on each day equal numbers of PR4
and PREXP rats were in each condition. A baseline day was
administered between test days, where rats were tested as normal and received a single pellet reward for each completed
trial. On the prefeeding probe days, rats were randomly
assigned to a prefeed or no prefeed (control) condition. Rats
within the prefeed condition were given 1 h of free access to
homecage lab chow prior to testing. Rats within the no prefeed
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control condition were tested as normal with chow provided
after the PR session was completed. Equal numbers of PR4
and PREXP rats were tested on both conditions on each test
day. Again, a baseline day was given between test days to
ensure no carry-on effects of prefeeding were observed upon
PR performance.

Dopaminergic manipulations
Pharmacological challenges were delivered in a withinsubject Latin square design. All drugs were dissolved in physiological saline and delivered via intraperitoneal injections at a
volume of 1 ml/kg of each rat’s body weight, 30 min prior to
PR testing. Rats were returned to their home cages for the post
injection period of 30 min. The D2/D3 receptor antagonist
s(−)raclopride(+)-tartrate salt (Sigma-Aldrich, Dorset, UK)
was administered at doses of 0, 0.03 and 0.3 mg/kg.
Following a 7-day washout period, d-amphetamine sulphate
(Sigma-Aldrich, Dorset, UK) was administered at doses of 0,
0.1 and 1 mg/kg.

Behavioural measures
The primary measure of interest was breakpoint (BP), defined as the number of target responses made in the last
successfully completed trial for each subject. The mean
post reinforcement pause (PRP), defined as the latency
between an animal removing its head from the magazine
following reinforcement and the first touchscreen target
response of the subsequent trial, was also assessed. The
total number of responses made for each reward earned
was calculated from the total number of touchscreen responses (therefore, including those made in incomplete trials) Response rates were analysed as previously described
(Simpson et al. 2011; Phillips et al. 2017). Briefly, response rates per trial were calculated by dividing the number of responses made in each trial by the time taken to
complete each trial, from the first response (therefore, excluding post reinforcement pauses). The first two trials in
each session were excluded from the response rate analyses. The first trial was excluded as it only involved a single
lever press, meaning it is not possible to calculate a response rate. The second trial was excluded as it only required two responses in the PREXP schedule. The low
number of responses needed in this condition may have
made comparison between groups problematic by inflating
the response rate within this group. The following negative
exponential function was then fitted to the mean response
rates per condition: y = −a*exp(x*b); with y being the response rate and x being the trial number. The predicted
peak response rate (a) and decay rate parameter (b) were
extracted and analysed across conditions. The predicted
peak response rate, the estimated point at which the
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function crosses the x-axis, is believed to provide a measure of the maximal motoric output of an animal. The decay rate has been proposed to reflect the effect of reinforcers upon subsequent bouts of responding, whereby a
slower rate of decay in responding reflects an increased
excitatory influence of rewards on subsequent behaviour
(Phillips et al. 2017). The decay rate parameter has also
been proposed to provide a measure of the rate of instrumental extinction (Simpson et al. 2011). Additional measures of motoric activity included the mean reward collection latency, the rate of IR beam breaks (beam breaks/sec),
the rate of non-stimulus (blank) touchscreen responses
(blank touches/sec) and the rate of magazine entries (magazine entries/sec)

Statistical analysis
Analysis was conducted in SPSS Version 23 (IBM, Armonk,
NY, USA) and the R software package (R Core Team 2017).
Graphs were produced using Prism (GraphPad, La Jolla, CA,
USA) and the ggplot2 package in R (Wickham 2009). To
compare the effects of schedule at baseline, independent t tests
were used. Levene’s test for equality of variance was
employed and corrected where appropriate. For all other tests,
repeated measures ANOVAs were employed. The
Greenhouse-Geisser correction was applied for any violations
of sphericity. All reported post hoc testing was adjusted using
the Bonferroni correction for multiple comparisons.

Results
Effect of reinforcement schedule on baseline PR
performance
All measures were collapsed across five PR sessions. The
mean breakpoint did not differ significantly according to
schedule group (t(22) = .051, p = .96; Fig. 1a). The mean duration of the PRP also did not differ across reinforcement
schedule groups (t(22) = 1.024, p = .317; Fig. 1b). The difference in the number of trials completed (and therefore rewards earned) did not reach statistical significance
(t(22) = 1.982, p = .060). Animals reinforced under the
PR4 schedule did, overall, make significantly more
touchscreen responses in total for each reward earned
(t(22) = 2.785, p < .05; Fig. 1c). There were no differences
between the mean number of IR beam breaks made per second (t(22) = 1.441, p = .164. Response rates appeared to differ between schedule groups (Fig. 1d). The predicted peak
response rate was significantly higher in animals reinforced
under the PREXP schedule (t(22) = 3.067, p < .01; Fig. 1e).
The response rate decay was also significantly greater in rats
tested under the PREXP schedule of reinforcement (t(22) =
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Fig. 1 Effects of schedule of
reinforcement on PR
performance. a The mean
breakpoint for both schedule
groups. b The duration of the post
reinforcement pause (PRP). c The
mean number of touchscreen
responses made per reward was
higher in animals reinforced with
the PR4 schedule. d The group
mean response rate for each trial,
from the third trial onwards for
both reinforcement schedule. e
Reinforcing animals under a
PREXP schedule significantly
increases the predicted peak
response rate. f Reinforcing rats
under a PREXP schedule
significantly increases the rate of
decay in responding. Error bars
represent ±SEM. *p < .05; **p
< .01

Table 1 Mean values ± SEM of additional measures activity for both
schedule types, as well as the number of rats in each condition that
completed the 45-min session without emitting a response for 180 s.
Additional motoric measures are of the reward collection latencies, rate

Baseline

Reward collection latency

Magazine entries/sec

Nontarget responses/sec

No. of 45-min terminations

PR4

PREXP

PR4

PREXP

PR4

PREXP

PR4

PREXP

1.20 ± 0.04*

1.58 ± 0.11*

0.08 ± 0.01

0.07 ± 0.01

0.03 ± 0.00

0.04 ± 0.01

33

14

1.36 ± 0.09#

0.05 ± 0.00#
0.08 ± 0.01#

0.02 ± 0.00
0.02 ± 0.00

0.03 ± 0.01
0.03 ± 0.01

5
8

2
6

Reward magnitude
1 pell
1.11 ± 0.06
3 pellets
Prefeeding
No feed
Prefeed
Raclopride
Vehicle
0.03 mg/kg
0.3 mg/kg
Amphetamine
Vehicle
0.1 mg/kg
1 mg/kg

of magazine entries (magazine entries per second), and the rate of
nontarget (blank) screen responses (nontarget responses/sec) for all
experimental conditions. Italic type signifies significant effects

0.97 ± 0.08

0.94 ± 0.12#

0.07 ± 0.01#
0.10 ± 0.01#

1.39 ± 0.09
1.27 ± 0.05

1.51 ± 0.13
1.56 ± 0.10

0.06 ± 0.01*
0.06 ± 0.01

0.05 ± 0.00*
0.04 ± 0.00

0.02 ± 0.00
0.02 ± 0.00

0.02 ± 0.00
0.03 ± 0.01

3
1

2
0

1.23 ± 0.09*
1.28 ± 0.06
1.44 ± 0.19*

1.63 ± 0.15*
1.58 ± 0.14
2.65 ± 0.72*

0.08 ± 0.01*
0.07 ± 0.01
0.05 ± 0.01†

0.06 ± 0.01*
0.05 ± 0.01
0.04 ± 0.00

0.02 ± 0.00
0.03 ± 0.01
0.01 ± 0.00†

0.03 ± 0.01
0.04 ± 0.02
0.02 ± 0.01

0
2
1

0
2
0

1.44 ± 0.09*
1.40 ± 0.08*
1.35 ± 0.06

1.80 ± 0.12*
1.71 ± 0.16*
1.56 ± 0.09

0.09 ± 0.01
0.08 ± 0.01
0.10 ± 0.01

0.06 ± 0.01
0.06 ± 0.01
0.09 ± 0.01†

0.04 ± 0.01
0.03 ± 0.01
0.05 ± 0.01

0.03 ± 0.01
0.03 ± 0.01
0.05 ± 0.01

1
1
6

0
2
8

*A significant group difference between schedule types, p < .05. # A significant effect of increasing the reward magnitude, p < .05. † A significant effect
relative to the vehicle condition p < .05
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3.177, p < .01; Fig. 1f). Supplementary measures of motoric
activity are available in Table 1.

Increasing the magnitude of the reward enhances PR
performance
Increasing the magnitude of reward significantly increased
breakpoint (F(1,22) = 35.183, p < .001; partial eta squared =
.615; Fig. 2a). Post hoc testing revealed that breakpoints were
significantly higher following three-pellet rewards in both
schedule groups (both p < .01). Breakpoints were not affected
by either schedule type or by any interaction between reward
magnitude and schedule (both p > .05). There were no significant effects of reward magnitude, schedule type or interaction
between the two upon either post reinforcement pausing
(Fig. 2b) or the rate of IR beam breaks (all p > .05).
Increasing reward magnitude also did not affect any additional
measure of activity (Table 1).
Changing the magnitude of reward had did not affect response rates in either schedule group (Fig. 2c, d). The

Fig. 2 Increasing the magnitude of reward facilitates PR performance. a
Reinforcing PR performance with three-pellet rewards significantly
increases breakpoints in both schedule groups. b Changing the
magnitude of reward does not alter the post reinforcement pause (PRP).
c The PR4 group mean response rate for each trial, from the third trial
onwards. d The PREXP group mean response rate for each trial, from the
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predicted peak response rate was not affected by either the
reward magnitude, schedule type or any interaction between
the two (all p > .05; Fig. 2e). The rate of decay in responding
was grater in rats reinforced under the PREXP schedule
(F(1,22) = 9.494, p < .01; partial eta squared = .301; Fig. 2f).
Post hoc testing revealed that the decay in responding was
higher in the PREXP when reinforced with three-pellet rewards (p < .05). The rate of decay in responding was not affected by either increasing the magnitude of rewards or by any
interaction between reward magnitude and schedule type
(p > .05).

Prefeeding with chow prior to testing reduces effort
expenditure
Prefeeding the rats with chow significantly reduced
breakpoints (F(1,22) = 22,796, p < .001, partial eta squared =
.509; Fig. 3a). Breakpoints were significantly lower following
prefeeding in both PR4 and PREXP schedule groups (both p
< .01). Breakpoints were not significantly affected by either

third trial onwards. e Increasing reward magnitude does not affect the
predicted peak response rate. f Increasing the magnitude of reward does
not affect the decay in responding. The PREXP group shows a greater
decay rate when reinforced with three-pellet rewards. Error bars represent
±SEM. *p < .05; **p < .01

Psychopharmacology (2018) 235:2739–2753
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Fig. 3 PR performance is supressed by prefeeding rats with homecage
chow prior to testing. a Breakpoints are significantly lowered by
prefeeding in both schedule groups. b Prefeeding with lab chow does
not affect the duration of the mean post reinforcement pause (PRP). c
The influence of prefeeding on the PR4 group mean response rate for

each trial, from the third trial onwards. d The influence of prefeeding on
the PREXP group mean response rate for each trial, from the third trial
onwards. e Prefeeding does not affect the predicted peak response rate. f
The decay rate was significantly increased after prefeeding with chow.
Error bars represent ± SEM. *p < .05; **p < .01

schedule of reinforcement or any interaction between schedule and prefeeding state (both p > .05). The duration of PRPs
was significantly affected by reinforcement schedule type
(F(1,22) = 4.494, p < .05, partial eta squared = .170); however,
no effect survived multiple comparison adjustments in post
hoc testing. The duration of the PRPs were not influenced
by either prefeeding state or any interaction between
prefeeding state and schedule type (both p > .05; Fig. 3b).
There were no significant effects on the rate of IR beam breaks
(all p > .05). Similarly, prefeeding had little effect on motoric
activity (Table 1).
The change in response rates following prefeeding were
analysed (Fig. 3c, d). The peak response rate was not significantly affected by either prefeeding state, schedule type
or any interaction between the two (all p > .05, Fig. 3e).
The rate of decay in responding was, however, significantly increased by prefeeding (F(1,22) = 9.839, p < .01;
Fig. 3f). Post hoc testing revealed a significant increase
in the rate of decay of responding in both schedule groups
following prefeeding (both p < .05). The rate of decay was

not significantly affected by either reinforcement schedule
or by any interaction between prefeeding state and reinforcement schedule both (p > .05).

Systemic administration of the D2/D3 receptor
antagonist raclopride impairs PR performance
Two rats did not make any touchscreen responses following
administration of 0.3 mg/kg raclopride; therefore, the data
from these animals were removed from all raclopride analyses. Administration of raclopride significantly reduced
breakpoints (F(2,40) = 14.113, p < .001; partial eta squared =
.414; Fig. 4a). Breakpoints were significantly reduced by administration of 0.3 mg/kg compared to vehicle in both schedule groups (p < .01). Breakpoints were not significantly affected by either reinforcement schedule or by any interaction between schedule type and raclopride administration (both
p > .05). The length of PRPs were significantly increased by
raclopride administration (F(1.498,32.962) = 8.955, p < .01;
partial eta squared = .289; Fig. 4b). Post hoc testing suggested
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80

**

b
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Veh
0.03 mg/kg
0.3 mg/kg

60
40
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PRP (s)

Breakpoint

a
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20

*
*

*

40

Veh
0.03 mg/kg
0.3 mg/kg

20

0

0
PR4

PREXP

PR4

PREXP

d

c

f

e
*
*

300
200

Veh
0.03 mg/kg
0.3 mg/kg

100
0

Decay Rate

Predicted Peak Response

400

0.6

Veh
0.03 mg/kg
0.3 mg/kg

0.4

0.2

0.0
PR4

PREXP

PR4

PREXP

Fig. 4 Systemic administration of raclopride disrupts PR performance. a
Raclopride administered at a dose of 0.3 mg/kg significantly disrupts
breakpoints reinforced under both PR4 and PREXP schedules. b
0.3 mg/kg raclopride significantly increases post reinforcement pauses
(PRPs) in the PR4 condition only. The duration of PRPs was also
significantly higher in the PR4 condition. c Suppression of response
rates by raclopride in the PR4 group for each trial, from the third trial

onwards. d PREXP group mean response rates are suppressed following
raclopride administration. e Raclopride administration does not
significantly affect the predicted peak response rate. Rats reinforced
with the PREXP schedule are estimated to have a significantly higher
peak response rate. f Raclopride administration did not significantly
affect the decay rate. Error bars represent ± SEM. *p < .05; **p < .01

that raclopride significantly increased pausing following administration of 0.3 mg/kg in the PR4 group (p < .05) but not
the PREXP group. There was also a significant interaction
between the dose of raclopride and reinforcement schedule
(F(1.498,32.962) = 5.042, p < .05; partial eta squared = .186),

suggesting that raclopride produced greater effects on pausing
in animals reinforced under the PR4 schedule. PRPs were also
significantly affected by schedule type (F(1,20) = 12.523, p
< .01); partial eta squared = .363). Post hoc testing revealed
that the mean PRP was significantly greater in the PR4 group
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following administration of both vehicle and 0.3 mg/kg
raclopride. Raclopride administration significantly reduced
the rate of IR beam breaks (F(1.309,26.185) = 6.298, p
< .01; partial eta squared = .239). Post hoc tests revealed that
0.3 mg/kg raclopride reduced the rate of beam breaks, relative
to administration of 0.03 mg/kg raclopride, in the PREXP
group only (p < .05). The rate of IR beam breaks was not
significantly affected by schedule type or by any interaction
between raclopride and schedule type (both p > .05).
Additional measures of motoric activity was largely unaffected by either dose of raclopride (Table 1).
Response rates following raclopride administration
were analysed (Fig. 4c, d). The predicted peak response
rate was significantly affected by schedule type
(F(1,20) = 15.662, p < .01; partial eta squared = .439;
Fig. 4e). Post hoc testing revealed that the PREXP
group had a significantly higher predicted peak response
rate following administration of vehicle and 0.3 mg/kg
raclopride. The peak response rate was not affected by
either raclopride administration or any interaction between raclopride and schedule type (both p > .05).
Administration of raclopride did, however, significantly
affect the decay in response rates (F(1.207, 24.142) =
5.860, p < .01; partial eta squared = .227; Fig. 4f).
However, post hoc testing did not reveal any significant
differences between doses. The decay in response rates
was not significantly affected by either schedule type or
by any interaction between schedule and raclopride administration (both p > .05).

Systemic d-amphetamine facilitates PR performance
Amphetamine administration significantly increased
breakpoints (F(1.169,25.711) = 47.935, p < .001; partial
eta squared = .685; Fig. 5a). Breakpoints were significantly greater in animals reinforced upon the PREXP schedule
(F(1,22) = 5.072, p < .05; partial eta squared = .187).
There was also a significant interaction between amphetamine and schedule type upon breakpoint (F(2,44) =
6.488, p < .01). Post hoc testing suggested 1 mg/kg amphetamine significantly increased breakpoint compared to
vehicle for animals on both PREXP and PR4 schedules of
reinforcement (both p < .05). However, breakpoints were
significantly higher following administration of 1 mg/kg
of amphetamine in the PREXP group. This finding indicates that amphetamine produced a greater effect upon
breakpoints in animals tested on an exponential schedule
of reinforcement compared to those on a linear reinforcement schedule. Amphetamine also had a significant effect
on the mean PRP duration (F(2,44) = 13.451, p < .001;
partial eta squared = .379; Fig. 5b). Post hoc testing revealed that 1 mg/kg amphetamine reduced the duration
of PRPs relative to vehicle in both schedule groups.
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PRPs were not significantly affected by either schedule
type or by any interaction between amphetamine and
schedule (both p > .05). Amphetamine administration significantly increased the rate of IR beam breaks (F(1.440,
31.673) = 38.390, p < .001; partial eta squared = .636).
Post hoc testing revealed that 1 mg/kg amphetamine increased the rate of beam breaks in both schedule groups
relative to vehicle (p < .01). The rate of IR beam breaks
was not significantly affected by either schedule or by any
amphetamine × schedule interaction (both p > .05). In addition, amphetamine had little effect on any of the supplementary measures of motoric activity (Table 1).
Systemic administration of amphetamine appeared to
enhance response rates (Fig. 5c, d). Amphetamine administration decreased the predicted peak response rate
(F(2,44) = 6.237, p < .01; partial eta squared = .221;
Fig. 5e). The predicted peak rate was reduced following
1 mg/kg amphetamine relative to all other doses (p
< .05) in the PREXP group only. The predicted peak
response rate was again significantly affected by schedule type (F(1,22) = 7.433, p < .05; partial eta squared =
.253). Post hoc testing revealed that the peak rate was
significantly higher in the PREXP group following administration of vehicle and 0.1 mg/kg amphetamine (p
< .05). There was no significant interaction between amphetamine and reinforcement schedule (p > .05). The
rate of decay in responding was significantly reduced
by amphetamine administration (F(2,44) = 25.548, p
< .001; partial eta squared = .537; Fig. 5f). Post hoc testing revealed that 1 mg/kg amphetamine reduced the rate
of decay relative to all other doses for both schedule
groups (p < .01). The rate of decay in responding was
not significantly affected by either schedule type or by
any interaction between amphetamine and schedule
(both p > .05).

Discussion
Touchscreen versions of PR have been developed to assess
motivation in mice (Heath et al. 2015), humans (Bland et al.
2016) and nonhuman primates (Weed et al. 1999).
Maintaining high face validity between species may increase
the likelihood of successful translation of findings (Bussey et
al. 2012). Additionally, development of a rat touchscreen variant of progressive ratio will allow for assessment of motivation in this species within the same environment and using the
same reinforcers earned in the assessment of more complex
behaviours (Horner et al. 2013; Mar et al. 2013; Oomen et al.
2013). In the present study, a novel rat touchscreen PR task
was assessed and found to be sufficiently sensitive for detecting changes in performance following outcome manipulations
and systemic administration of dopaminergic drugs
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Fig. 5 Facilitation of PR performance following systemic administration
of d-amphetamine. a Administration of 1 mg/kg d-amphetamine
significantly increases breakpoints in both schedule groups. Breakpoints
are significantly higher in the PREXP group relative to rats reinforced
under the PR4 schedule following administration of 1 mg/kg
amphetamine. b The duration of the mean post reinforcement pause
(PRP) is significantly reduced by 1 mg/kg amphetamine, in both reinforcement schedule conditions. c Enhancement of response rates

following administration of amphetamine in rats reinforced with the
PR4 schedule. d Response rates are enhanced following administration
of amphetamine in rats reinforced with the PREXP schedule. e
Amphetamine significantly reduces the predicted peak response rate in
animals reinforced under the PREXP schedule only. The decay rate of
responding is significantly reduced in rats in both schedule groups. Error
bars represent ±1 SEM. *p < .05; **p < .01

previously found to be efficacious in non-touchscreen versions of the schedule (e.g. Poncelet et al. 1983; Skjoldager et

al. 1993; Cheeta et al. 1995; Schmelzeis and Mittleman 1996).
The similarity in results across these different procedures
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further strengthens the use of measurement of responding under PR schedules of reinforcement to assay motivation.
Furthermore, this represents the successful validation of the
task for use in the rat touchscreen operant response system.

Responding under a progressive ratio schedule
of reinforcement as an assay of motivation
PR schedules are widely used, across species, to probe motivated behaviour. In spite of their common usage, PR schedules have a number of limitations, which have previously
noted (Stewart 1975; Richardson and Roberts 1996; Killeen
et al. 2009). Breakpoint is an unspecific measure and could
reflect non-motivational changes in behaviour. Additionally,
PR schedules can vary substantially in how the schedule of
reinforcement progresses. As a consequence, it is not clear
whether it is appropriate to compare PR performance between
studies. The present study addresses some of these concerns.
Firstly, we examined the dynamics of within-session changes
in behaviour as a complementary measure to breakpoint.
Specifically, we analysed the peak response rate as a measure
of the initial motoric output and the rate of decay as an index
of the motivational effects of reinforcers upon subsequent
bouts of behaviour. Additionally, we compared behavioural
performance between two markedly different schedules of
reinforcement. The purpose of this was to see if, in otherwise
equally motivated rats, interventions produced comparable
effects on behaviour reinforced by different PR schedules.
As behaviour was largely equally affected, it strengthens the
case for results to be compared between studies that use different parameters.
An additional concern is that the decrease in responding
towards the end of session could reflect a progressive satiation, rather than a reflection of the increasing effort costs
(Hodos and Kalman 1963). Presently, the reward magnitude
manipulation also suggested that progressive satiation was not
affecting performance. Increasing the magnitude of rewards
has been reported to affect breakpoints in an ‘inverted U’
fashion, with an initial facilitation in PR performance before
decreasing breakpoints as animals become satiated (Hodos
and Kalman 1963). As increasing the reward magnitude increased breakpoints, it suggests that rats had not yet reached
the point where progressive satiation had begun to affect
performance.

Effect of reinforcement schedule on PR performance
Both linear and exponential schedules of reinforcement are
widely used in PR tasks. The reinforcement schedule determines the number of operant responses required for each reward. Relative to the linear PR4 schedule, the PREXP schedule has an initially low response requirement for reinforcement which increases rapidly in subsequent trials. In the
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absence of any additional manipulations, breakpoints were
remarkably similar between the two schedules (Fig. 1a).
This is in spite of the difference in the total number of screen
responses needed to achieve these breakpoints (Fig. 1c).
Although, this finding may not generalise to every PR schedule, it indicates that prior history of reinforcement (at least
within a session) is not the primary determinant of breakpoint.
However, we did observe differences in the pattern of response rates between schedules. The initial predicted peak
response rate was significantly higher in the PREXP schedule.
Furthermore, rats reinforced under the PREXP schedule also
displayed a significantly greater rate of decay in responding.
The group differences observed are likely a reflection of the
lower work requirements in the first few analysed trials in the
PREXP condition, before a rapid increase in ratio requirements. Both the predicted peak response rate and decay rate
appear independent of breakpoint. Examination of both whole
and within-session measures may help to better understand
motivational states of organisms during PR performance.

Outcome manipulations
Increasing the magnitude of rewards resulted in a significant
increase in breakpoints, in line with previous reports
(Skjoldager et al. 1993; Eagle et al. 1999; Rickard et al.
2009). Larger magnitude rewards increase the vigour of operant responding (Skjoldager et al. 1993). This greater behavioural activation allows organisms to overcome greater effort
costs to obtain rewards, resulting in higher breakpoints.
Breakpoints may represent the outcome of a cost/benefit decision making process (Salamone et al. 2009). If an action or
series of actions lead to a greater benefit (e.g. a larger food
reward), then an organism should be more willing to overcome greater costs to obtain the goal. The rat touchscreen
PR task was also sensitive to the effects of outcome devaluation through prefeeding. This is also in line with previous
reports showing that inducing both specific (Skjoldager et al.
1993) and nonspecific satiety (Eagle et al. 1999) results in a
reduction in breakpoints. Prefeeding with chow would be expected to devalue the reinforcer and reduce the effort an organism is willing to expend to receive the reward.
The length of PRPs was not significantly affected either by
changing reward magnitudes or prefeeding. PRPs increase
with the ratio requirements (Powell 1969; Baron et al.
1992). Increasing reward magnitudes increases trial completion and therefore the average ratio requirement within a session. This would be expected to increase the length of the
average PRP. This result may explain why, overall, larger
magnitude rewards did not decrease pausing. PRPs were also
unaffected by prefeeding rats with homecage chow. This
matches previous findings (Skjoldager et al. 1993; Eagle et
al. 1999) of prefeeding on pausing under PR schedules. This is
in contrast to the effects observed under FR schedules, where
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prefeeding animals has been reported to increase the duration
of PRPs (Sidman and Stebbins 1954). Again, this may be as a
result of prefeeding decreasing the total number of trials completed, and therefore decreasing the mean ratio requirement in
these sessions. Together, this highlights a potential confound
in evaluating performance based upon mean PRP across a PR
session, without controlling for the total number of trials
completed.
Neither increasing the reward magnitude nor prefeeding
significantly altered the peak response rate. This is in agreement with the view that this variable reflects some measure of
maximal motoric output (Phillips et al. 2017). Increasing the
magnitude of reward also did not significantly affect the rate
of decay in touchscreen responding. Previous reports suggest
the efficacy of different food reinforcers in supporting PR
performance does not appear to affect response rate decay
(Kim et al. 2017). Therefore, it is not surprising that larger
magnitude rewards do not affect the rate of decay, in spite of
larger rewards supporting higher breakpoints. This further
supports the hypothesis that the rate of decay reflects the qualitative effects of reinforcers upon behaviour, rather than a
measure of behavioural activation. In contrast, reward devaluation through prefeeding significantly increased the rate of
decay of responding. It is likely, therefore, that each food
reward earned has a reduced ability to activate and support
subsequent effortful behaviour resulting in an accelerated decay in response rates.

Dopaminergic manipulations
Effort-based responding is highly sensitive to dopaminergic
manipulations (Salamone and Correa 2012). Presently, systemic administration of raclopride and amphetamine increased
and decreased breakpoints, respectively. This is in line with
previous reports in lever-based versions of PR (Poncelet et al.
1983; Cheeta et al. 1995; Aberman et al. 1998), as well as in
the mouse touchscreen version (Heath et al. 2015). It should
be noted that as two rats failed to produce any touchscreen
responses following the high dose of raclopride, it is possible
that this dose also produced additional non-motivational effects such as impairing motoric function, in these rats.
Additionally, in the remaining rats, the reward collection latency was increased (Table 1). However, the initial rate of
responding was intact in these rats (Fig. 4e), suggesting the
effects of raclopride upon PR performance were unlikely entirely a consequence of motoric disruption.
Amphetamine significantly increased breakpoints on both
schedule types. However, amphetamine was able to produce a
greater effect on breakpoints in animals reinforced under the
PREXP schedule of reinforcement (Fig. 5a). This suggests
that this schedule may have higher sensitivity, to detect changes in breakpoint, than the linear schedule employed in this
study. Exponential PR schedules are commonly used in drug
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self-administration studies (Richardson and Roberts 1996).
The rapidly increasing response requirement in later trials reduces the risk of ceiling effects in time-limited sessions
(Roberts et al. 1989). In a similar vein, exponential schedules
allow higher breakpoints to be reached with fewer responses
and fewer rewards earned. This may reduce the influence of
motor fatigue and/or satiety affecting the enhancement of
breakpoints. It is unclear whether the present results would
generalise to different linear PR schedules of reinforcement,
but does suggest that certain reinforcement schedules can have
differential sensitivity to detecting enhancements in motivated
behaviour.
Both raclopride and amphetamine affected the duration of
the PRPs. Amphetamine has previously been reported to decrease the length of PRPs (Evenden and Robbins 1983),
whereas D2 receptor antagonists appear to increase pausing
(Salamone 1986). The effects of dopaminergic compounds on
PRP were in contrast to the lack of effects observed following
the outcome modulations. The magnitude of the effects produced by the higher doses of raclopride and amphetamine
appeared far larger than those produced by prefeeding and
increasing reward magnitude. It may be the case that PRP as
a measure is not as sensitive to changes in motivated behaviour as breakpoint, and larger effects are needed to detect
significant changes in this measure. The present effects of
amphetamine and raclopride upon PRP were not observed in
the mouse touchscreen version of PR (Heath et al. 2015).
Similarly, in this study, amphetamine had marked effects upon
nonspecific locomotor activity in rats, but no effects were
detected in mice performing the analogous task in a prior
study (Heath et al. 2015). Species differences between mice
and rats have been observed in a number of behavioural assays
(see Young et al. 2013 for a review). The present results suggest an increased sensitivity to dopaminergic drugs in rats,
relative to mice at equivalent doses. Few studies compare
the two species, but there have been reports of differences in
dopaminergic function in mice and rats under certain circumstances (e.g. Konstandi et al. 2000; Ralph-Williams et al.
2003).
Another notable result was the effect of amphetamine on
the pattern of response rates. The high dose of amphetamine
reduced both the peak response rate and the rate of decay in
responding. The reduced initial peak rate may be a reflection
of the anxiogenic and/or appetite supressing effects of amphetamine (MacPhail and Gollub 1974; Lapin 1993). The
reduction in the rate of decay may have been a result of amphetamine altering the rats’ response to extinction. The low
frequency of reinforcement relative to responding may result
in extinction in later PR trials (Killeen et al. 2009). A slower
decay in response rates may have reflected an increased resistance to extinction. However, if this were the case, it may have
been expected that a greater effect upon the rate of decay
would be observed in the PREXP group. The sharper increase
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in ratio requirements observed in the exponential schedule
suggests a greater likelihood of extinction occurring relative
to the linear schedule used in the PR4 group. As amphetamine
reduced the rate of decay similarly in both groups, an increase
in resistance to extinction is unlikely to be the sole explanation
for a reduction in the rate of decay. A previous study, investigating within session changes in response rates reported that a
similar dose of amphetamine (0.8 mg/kg), increased the activating or motivational effects of reinforcers upon behaviour
(Mobini et al. 2000). The reduced rate of decay observed
presently may reflect an increase in the behavioural activation
following each reinforcer. As a consequence, each reinforcer
is able to support behaviour for longer, which may also underlie, at least in part, the increased breakpoints following the
high dose of amphetamine.

Comparisons to other PR tasks
It is worth noting that, in the absence of any additional manipulations, breakpoints are lower in touchscreen PR than
those observed in lever-press PR schedules. For example,
across both linear and exponential schedule types, breakpoints
in excess of 100 are typically observed in lever-responding
rats (Skjoldager et al. 1993; Bezzina et al. 2015; OlarteSánchez et al. 2015). Therefore, the present findings of rats
returning breakpoints in the region of ~ 45–55 are considerably lower than those seem with levers. The rate of operant
responding is highly sensitive to physical characteristics such
as the height of the lever (Skjoldager et al. 1993) and the
required response force (Alling and Poling 1995). The
touchscreen used in the present study use IR photocells to
record screen touches (in fact, the rat is not strictly speaking
required to ‘touch’ the screen). Therefore, touchscreen
responding would be expected to require less physical effort
than responding on a lever. The differences in breakpoint,
therefore, cannot be explained in terms of force requirements.
One possibility is that the biophysical feedback from
touchscreen responding is considerably less than that obtained
by pressing a lever. In turn, there may be less salient cues to
associate with reward. Pavlovian cues associated with reward
are able to strongly influence instrumental behaviour
(Rescorla and Solomon 1967). The reduced salience of cues
associated with touchscreen responding relative to lever pressing may therefore reduce their invigorating effects upon
responding (e.g. Saunders and Robinson 2011).
A separate possibility is the delay between response and
reward. Increasing the delay from a response to a reward will
shift behaviour to obtaining an immediately available, but less
preferred reward (Thiébot et al. 1985). In the current
touchscreen PR task, it is only possible to make a response
every 0.5 s. This is due to a brief stimulus offset, added to
provide visual feedback that a response has been made (see
Methods). As a consequence, the rate of responding would be
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expected to be lower than a lever-based version of PR where
rats are able to make multiple lever responses every second
(e.g. Olarte-Sánchez et al. 2015). The longer time taken to
complete each ratio may increase the costs associated with
obtaining reward and result in animals ceasing responding
earlier. The reduced breakpoints and response rates in
touchscreen PR may confer certain advantages: the avoidance
of ceiling effects that may obscure potential faciliatory effects
of interventions, particularly when using time-limited schedules, and a lower number of responses which may reduce the
potentially confounding influences of satiation and motor fatigue upon performance.
Taken together, this study demonstrates the successful
adaption and validation of progressive ratio for the rat operant
touchscreen system. Like the mouse touchscreen- and traditional lever-based versions, the rat touchscreen PR variant is
sufficiently sensitive to detect bidirectional changes in motivated behaviour following outcome manipulations and dopaminergic drugs. Furthermore, this study demonstrates that the
use of exponential schedules of reinforcement may provide a
greater sensitivity to detecting the effects of compounds that
enhance PR performance. Additionally, this study demonstrates the utility of the complementary approach of studying
within-session changes in behaviour in addition to cumulative
parameters, such as breakpoint. Finally, effort-based motivated behaviour can now be assayed, with high face validity,
across species.
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